Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom.

Andrea V MargulisMarie LinderAlejandro AranaAnton PottegårdIna Anveden BerglindChristine L BuiNina Sahlertz KristiansenShahram BahmanyarLisa J McQuayWillem Jan AtsmaKwame AppentengMilbhor D'SilvaSusana Perez-GutthannJesper Hallas

Published in: PloS one (2018)

In these cohorts, persistence with antimuscarinic drugs was low. By 2012, the preferred drug was solifenacin; oxybutynin use was marginal in Nordic countries compared with the UK.

Keyphrases

drug induced
cross sectional
emergency department